Medical Endoscopic Orthopedics General Plasma Surgery For Turbinate Reduction

Technical Parameters

Product Features:

 General Plasma Surgery uses minimally invasive ablation technology to gently dissolve submucosal tissue at the molecular level while preserving the mucosal surface during turbinate reduction procedures. The device has a distal ablative electrode and a proximal thermal electrode that simultaneously removes and shrinks tissue. The 1st polar and the 2nd poler form a circuit for channeling while the 2nd and the 3rd polar form a circuit for ablation, hemostasis and coagulation.

Functions:

1. Unparalleled Patient Comfort and Minimally Invasive Advantage

• Minimal Physical Distress:
  • This plasma - based prostatectomy system ushers in a new era of patient - centric care. Patients experience an extraordinary reduction in suffering during and after the procedure. Unlike traditional open - surgery methods that involve large incisions, the plasma surgery is a non - invasive or minimally invasive approach, eliminating the need for any external incisions on the body surface. This not only reduces the immediate pain associated with large surgical incisions but also minimizes the risk of postoperative wound - related complications such as infections and scarring.
• Rapid Recovery:
  • The minimally invasive nature of this prostatectomy technique leads to a significantly faster recovery period. With minimal damage to the surrounding tissues, patients can expect to return to their normal daily activities much sooner compared to other surgical options. There is less disruption to the body's normal physiological functions, allowing for a more seamless recovery process. For example, patients may experience shorter hospital stays, reduced need for extended convalescence at home, and a quicker resumption of work and social activities.

2. Drastically Reduced Complications

• Lower Incidence of Urethral Stenosis:
  • In contrast to other prostatectomy procedures, the plasma surgery system for the prostate demonstrates a remarkable reduction in the occurrence of postoperative urethrostenosis. The precise and controlled nature of the plasma - based ablation and resection helps to avoid excessive damage to the urethral tissues. By minimizing trauma to the urethra during the removal of prostate tissue, the risk of scarring and subsequent narrowing of the urethra is greatly mitigated. This is crucial as urethrostenosis can lead to significant urinary problems, including difficulty in urination, urinary retention, and recurrent urinary tract infections.
• Minimal Uracratia Risk:
  • Uracratia, or involuntary leakage of urine, is a common concern after prostate surgery. However, with the advanced technology of this plasma system, the incidence of uracratia is substantially lower. The system's ability to accurately target and remove prostate tissue while preserving the integrity of the urinary sphincter and surrounding muscles is key. This precision ensures that the normal urinary control mechanisms are less likely to be disrupted, providing patients with a greater sense of security and quality of life post - surgery.
• Fewer Postoperative Urinary Tract Infections:
  • The reduced risk of postoperative urinary tract infections is another significant advantage of this plasma surgery system. The lack of large incisions and minimal tissue damage mean there are fewer entry points for bacteria to invade the urinary tract. Additionally, the faster recovery time and the body's ability to quickly resume normal urinary function contribute to a lower likelihood of infection. This is in stark contrast to other surgeries where the disruption of the normal urinary flow and the presence of surgical wounds can provide an ideal environment for bacterial growth.
• Significantly Reduced Postoperative Bleeding:
  • Postoperative bleeding is a major complication in many prostatectomy procedures. The plasma surgery system, however, offers enhanced hemostasis capabilities. The plasma energy can effectively seal blood vessels during the resection process, reducing the amount of bleeding both during and after the surgery. This not only improves the safety of the procedure but also decreases the need for additional interventions to control bleeding, such as blood transfusions or secondary surgical procedures. Overall, it provides a more stable and less - risky postoperative course for patients.
  •